Vir Biotechnology, Inc.
VIR
$10.88
-$0.31-2.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 299.84M | 60.58M | 61.78M | 11.13M | 13.27M |
| Total Other Revenue | 3.39M | 4.92M | 6.78M | 5.73M | 5.73M |
| Total Revenue | 303.23M | 65.50M | 68.56M | 16.86M | 19.00M |
| Cost of Revenue | 485.00M | 447.24M | 455.04M | 469.53M | 513.30M |
| Gross Profit | -181.78M | -381.74M | -386.49M | -452.67M | -494.30M |
| SG&A Expenses | 99.38M | 91.47M | 92.07M | 95.16M | 98.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 584.38M | 538.71M | 547.12M | 564.68M | 611.97M |
| Operating Income | -281.16M | -473.21M | -478.56M | -547.82M | -592.97M |
| Income Before Tax | -251.30M | -442.35M | -437.77M | -499.39M | -549.95M |
| Income Tax Expenses | 380.00K | 371.00K | 217.00K | 268.00K | 277.00K |
| Earnings from Continuing Operations | -251.68 | -442.72 | -437.99 | -499.65 | -550.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -251.68M | -442.72M | -437.99M | -499.65M | -550.23M |
| EBIT | -281.16M | -473.21M | -478.56M | -547.82M | -592.97M |
| EBITDA | -269.65M | -461.59M | -466.88M | -536.16M | -581.41M |
| EPS Basic | -1.86 | -3.14 | -3.16 | -3.62 | -4.01 |
| Normalized Basic EPS | -1.15 | -1.94 | -1.98 | -2.27 | -2.46 |
| EPS Diluted | -1.87 | -3.14 | -3.16 | -3.62 | -4.01 |
| Normalized Diluted EPS | -1.15 | -1.94 | -1.98 | -2.27 | -2.46 |
| Average Basic Shares Outstanding | 593.24M | 563.97M | 554.08M | 551.66M | 549.38M |
| Average Diluted Shares Outstanding | 594.40M | 563.97M | 554.08M | 551.66M | 549.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |